Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
3
institutions
Market cap
$12.6B
231M shares
52-week range
$35.53 – $71.04
58% from low
Sector
SECURITY BROKERS, DEALERS & FLOTATION COMPANIES
Exchange
NYSE
CS
Jefferies Financial Group is a full-service investment banking and capital markets firm that was founded in 1962. After nearly 30 years of focusing on institutional trading services, it entered the investment banking industry in the early 1990s, which ultimately grew into the core business. In 2013, Jefferies merged with Leucadia, a manufacturing-focused holding company. Since the merger, Jefferies became the core of the combined business as the bulk of the legacy portfolio was sold off and the parent company was renamed to match the subsidiary. Within the investment banking landscape, Jefferies predominately serves the North American middle market and has captured considerable market share over the past decade.
www.jefferies.comNo one on the platform currently holds JEF.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-06-30 | 537,589 | $29.4M |
| Berkshire Hathawayas of 2026-03-31 | 433,558 | $17.9M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-08-18 | $0.4000 | 2026-08-28 |
| 2026-05-18 | $0.4000 | 2026-05-29 |
| 2026-02-17 | $0.4000 | 2026-02-27 |
| 2025-11-17 | $0.4000 | 2025-11-26 |
| 2025-08-18 | $0.4000 | 2025-08-29 |
| 2025-05-19 | $0.4000 | 2025-05-29 |
| 2025-02-14 | $0.4000 | 2025-02-27 |
| 2024-11-18 | $0.3500 | 2024-11-27 |
| 2024-08-19 | $0.3500 | 2024-08-30 |
| 2024-05-17 | $0.3000 | 2024-05-30 |
No one on the platform has traded JEF yet.
| 35,848 |
| $1.5M |
| 2024-02-15 | $0.3000 | 2024-02-27 |
| 2023-11-10 | $0.3000 | 2023-11-28 |
| Execution date | Ratio |
|---|---|
| 2006-06-15 | 2-for-1 |
| 2005-01-03 | 3-for-2 |
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $8.5B | +17.1% | $3.56 | $3.13–$3.90 | 15.7× | 4 |
| 2027 | $9.4B | +10.0% | $4.78 | $3.93–$5.30 | 11.7× | 4 |
| 2028 | $10.2B | +8.3% | $5.40 | $2.40–$6.99 | 10.4× | 4 |
| 2029 | $10.1B | -0.6% | $3.17 | $2.75–$3.64 | 17.7× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-06-24 | $1.16 | $1.03 | -11.2% |
| 2026-03-25 | $0.89 | $0.72 | -19.5% |
| 2026-01-07 | $0.88 | $0.89 | +1.6% |
| 2025-09-29 | $0.80 | $1.05 | +31.3% |
| 2025-06-25 | $0.44 | $0.43 | -2.3% |
| 2025-03-26 | $0.94 | $0.60 | -36.1% |
| 2025-01-08 | $0.85 | $1.05 | +23.5% |
| 2024-09-25 | $0.78 |
| $0.75 |
| -3.8% |
| $12.3B |
| — |
| GLXYGalaxy Digital | $20.95 | -0.62% | $6.9B | — |
| HLIHoulihan Lokey, Inc. | $132.21 | +7.12% | $9.2B | — |
Source: Financial Modeling Prep · peers by sector/industry
Latigo Biotherapeutics rose Friday after the clinical-stage biopharmaceutical company raised $345.6 million in an upsized IPO priced at the top of its marketed range. The Thousand Oaks, California-based company sold 19.2 million shares at $18 each, above its initial offering of 16 million shares at $16-$18. Shares opened at $21 on Nasdaq Global Select Market, giving Latigo an estimated market capitalization of about $1.3 billion based on its reported shares outstanding. Latigo develops non-opioid pain treatments designed to block pain transmission without addiction risk. Its lead candidate, LTG-001, is an oral Nav1.8 inhibitor intended to provide rapid relief while reducing reliance on opioids for acute pain. Goldman Sachs, Jefferies, Leerink Partners and Guggenheim Securities served as joint bookrunners. Underwriters have a 30-day option to purchase up to 2.88 million additional shares at the IPO price, less discounts and commissions. $GS $JEF
View on StockTwits ↗$WSO $HAS $GNRC $MOG.B $JEF Watsco benefits from HVAC demand, Hasbro leverages entertainment brands, Generac benefits from backup power demand, Moog Class B provides aerospace exposure, and Jefferies benefits from investment banking activity.
View on StockTwits ↗$XPEV does someone understand why Xpeng does not explode above $50 when $JEF $BAC $C all have price targets for Xpeng which are above $25? Why is it at only $12 although Xpengs are selling like hot chocolate in Europe and especially in germany. So hot https://www.xpeng.com/de
View on StockTwits ↗$JEF JEFFERIES GETS NEW EVIDENCE OF FAKE INVOICES AT TROUBLED FUND; reminds me of the movie "The Firm"
View on StockTwits ↗Wall St is expecting 0.95 EPS for $JEF Q3 [Reporting 09/30 AMC] http://www.estimize.com/intro/jef?chart=historical&metric_name=eps&utm_cont
View on StockTwits ↗$JEF Jefferies faces fresh trouble at fund it was already shuttering
View on StockTwits ↗$GLNCY $JEF $ISNPY >Jefferies seems to be in the news for all the wrong reasons lately. They have trade-finance-related exposure of about $300 million to Radiant World through its Point Bonita fund. >Intesa Sanpaolo (Italy’s biggest bank) booked financial provisions on a roughly €200 million ($230 million) exposure to Radiant World, noting the position is largely covered with no impact on 2026 net profit guidance.
View on StockTwits ↗Jersey Mike’s priced its IPO at $23 per share, offering 43.5 million Class A shares and raising roughly $1 billion in one of the largest restaurant-sector public offerings of the year. The stock is scheduled to begin trading on the New York Stock Exchange under the ticker JMKE on July 30, with the transaction expected to close on July 31. The offering includes both newly issued shares and shares sold by existing investors. Jersey Mike’s will use proceeds from the sale of approximately 13.8 million new shares to repay certain outstanding debt and support general corporate purposes, while proceeds from shares sold by existing shareholders will not go to the company. Underwriters also have a 30-day option to purchase up to 6.5 million additional shares to cover potential overallotments. Morgan Stanley, Jefferies, and J.P. Morgan are serving as lead underwriters for the offering. $MS $JEF $JPM
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.